Search

Zentalis Pharmaceuticals Inc

Nyitva

4.47 -10.96

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

4.57

Maximum

5.34

Fő mutatók

By Trading Economics

Bevétel

-136K

-35M

Egy részvényre jutó nyereség

-0.503

Munkavállalók

106

EBITDA

2.2M

-35M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+33.13% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. aug. 4.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

62M

357M

Előző nyitás

15.43

Előző zárás

4.47

Zentalis Pharmaceuticals Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. júl. 22. 23:56 UTC

AAR Corp shares are higher in after-market hours, reflecting earlier fluctuations. The stock remains below its 20-day moving average and near its one-month trading range.

2026. júl. 22. 23:56 UTC

Correlated Moves
News

American Water Works Company Inc. is trading lower in after-market hours amid geopolitical tensions and rising crude oil prices impacting market sentiment.

2026. júl. 22. 23:56 UTC

HCA Healthcare Inc shares are trading higher in after-market hours. Broader market sentiment is influenced by geopolitical tensions and rising crude oil prices.

2026. júl. 22. 23:56 UTC

Correlated Moves

Lyft Inc shares are higher in after-market trading, showing a slight increase since Wednesday's close amid broader market dynamics and fluctuations in the ride-sharing sector.

2026. júl. 22. 23:56 UTC

Correlated Moves

Costco Wholesale shares are lower in after-market hours amid ongoing geopolitical tensions and rising crude oil prices affecting market sentiment.

2026. júl. 22. 23:56 UTC

ETF Constituents

The iShares Biotechnology ETF is trading higher in after-market hours, supported by gains from Medpace Holdings and other key holdings.

2026. júl. 22. 23:56 UTC

Correlated Moves

Element Solutions Inc shares are higher in after-market trading, reflecting a modest gain. Similar trends were noted in correlated asset ITT Inc.

2026. júl. 22. 23:56 UTC

Correlated Moves

Coeur Mining Inc shares are lower in after-market hours, reflecting a decline linked to a slight drop in silver prices.

2026. júl. 22. 23:56 UTC

Badger Meter Inc shares are higher in after-market trading, recovering from earlier volatility without any specific news to explain the movement.

2026. júl. 22. 23:56 UTC

Correlated Moves

Rambus Inc shares are higher in after-market trading, reflecting positive movement since Wednesday's close, alongside gains in MACOM Technology Solutions. Geopolitical tensions persist.

2026. júl. 22. 23:56 UTC

Exelon shares are lower in after-market trading, reflecting stable performance within a one-month trading range. No specific news was identified.

2026. júl. 22. 23:56 UTC

American Superconductor shares are lower in after-market trading, retracing from earlier gains and remaining below their 20-day moving average.

2026. júl. 22. 23:56 UTC

NextDecade Corp. shares are lower in after-market hours amid geopolitical tensions and rising oil prices, reflecting routine fluctuations without specific company news.

2026. júl. 22. 23:56 UTC

Comfort Systems USA Inc shares are lower in after-market trading, following a trend of higher closes. No specific news was identified for this movement.

2026. júl. 22. 23:56 UTC

MasTec Inc. shares are modestly higher in after-market hours, with no specific company news identified. Broader market sentiment may be influenced by geopolitical tensions.

2026. júl. 22. 23:56 UTC

Correlated Moves

Fortuna Silver Mines Inc. is trading lower in after-market hours, reflecting broader declines in the precious metals market amid ongoing geopolitical tensions.

2026. júl. 22. 23:56 UTC

News

Wynn Resorts received approval to expand its Wynn Palace resort in Macau, including a new hotel and entertainment center. Shares showed little change in after-market trading.

2026. júl. 22. 23:56 UTC

Intellia Therapeutics Inc shares are higher in after-market trading, though they remain below their 20-day moving average and near the lower end of their one-month range.

2026. júl. 22. 23:56 UTC

ETF Constituents

iShares China Large-Cap ETF declines after market close, impacted by JD's negative return. The ETF remains above its 20-day moving average.

2026. júl. 22. 23:56 UTC

Newmont Corporation shares are higher in after-market hours, reflecting a modest increase since Wednesday's close, with no specific news identified for the movement.

2026. júl. 22. 23:56 UTC

Under Armour Inc shares are slightly higher in after-market hours, maintaining a position near the upper end of their one-month range.

2026. júl. 22. 23:52 UTC

Lumentum Holdings Inc shares are higher in after-market trading, significantly above Wednesday's close and near the upper end of its one-month trading range.

2026. júl. 22. 23:51 UTC

Blue Owl Capital Corp shares are higher in after-market trading. No specific news was identified to explain this movement amid cautious broader market sentiment.

2026. júl. 22. 23:51 UTC

Upwork Inc. shares are lower during after-market hours amid broader market declines. Rising crude oil prices and geopolitical tensions are contributing to negative sentiment.

2026. júl. 22. 23:51 UTC

MACOM Technology Solutions is higher in after-market trading, reflecting positive sentiment despite broader market concerns over rising crude oil prices and geopolitical tensions.

2026. júl. 22. 23:51 UTC

Pinnacle West Capital Corp shares are lower in after-market trading, continuing weak sentiment from earlier. Broader market dynamics may be influencing cautious investor sentiment.

2026. júl. 22. 23:51 UTC

HP Inc. shares are little changed in after-market trading. The broader market is lower amid rising crude oil prices and uncertainty over the Fed's interest rate decision.

2026. júl. 22. 23:51 UTC

Ambarella Inc shares are higher in after-market trading, recovering from earlier fluctuations. Broader market sentiment remains cautious amid rising crude oil prices.

2026. júl. 22. 23:51 UTC

Correlated Moves

Photronics Inc shares are higher in after-market trading, supported by a positive trend and correlations with MACOM Technology Solutions Holdings Inc.

2026. júl. 22. 23:51 UTC

PDD Holdings Inc shares are higher in after-market trading, despite no specific news driving the price movement. The stock remains above its 20-day moving average.

Társak összehasonlítása

Árváltozás

Zentalis Pharmaceuticals Inc Előrejelzés

Célár

By TipRanks

33.13% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 6.67 USD  33.13%

Magas 10 USD

Alacsony 4 USD

7 Wall Street elemző 12 hónapos célárain alapulva a(z)Zentalis Pharmaceuticals Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

7 ratings

4

Vétel

3

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat